Skip to main content

Canadian pot stocks surged for a second straight session Monday amid speculation more alcohol companies will strike deals with marijuana growers as Canada marches closer to legalization.

Shares of Nanaimo, B.C.-based Tilray Inc. jumped as much as 23 per cent to $54.16, a record high, while peer Cronos Group Inc. soared 30 per cent on the Nasdaq, the biggest intraday gain since January. Aphria Inc. rose as much as 20 per cent in Toronto, while Aurora Cannabis increased 8.4 per cent.

Diageo Plc, the maker of Guinness beer, is holding discussions with at least three Canadian cannabis producers about a possible deal, BNN Bloomberg Television reported last week. Earlier this month, Constellation Brands Inc., the brewer of Corona, announced it will spend $3.8 billion to increase its stake in Canopy Growth Corp., the largest deal in Canada’s nascent marijuana industry. Molson Coors Brewing Co. is also starting a joint venture with Hydropothecary Corp. to develop cannabis drinks in Canada.

Story continues below advertisement

More alcoholic beverage companies are likely to strike deals with Canadian marijuana producers now that Diageo is looking to enter the space, Cowen & Co. analyst Vivien Azer said Monday in a note. Tilray is “an attractive partner” for an alcohol company due to its broad portfolio of consumer brands, many of which are commercially available in the U.S., she said. Tilray, which was taken public by Cowen in July, now has a market value of almost $5 billion.

“We expect more alcoholic beverage companies to announce deals with Canadian LPs over the course of the year,” Azer said in the note.

The BI Canada Cannabis Index rose 4.1 per cent, its ninth straight gain and is heading for the longest rally ever. The index, which has a combined value of $80-billion, has slumped 31 per cent in 2018 amid concerns the emerging market was overvalued.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter